LICENSE AGREEMENTLicense Agreement • May 23rd, 2019 • Med-X, Inc. • Pharmaceutical preparations • California
This License Agreement (the “Agreement”) is made as of the 15th day of January, 2010 by and between Matthew Mills, an individual (“Licensor”), and Pacific Shore Holdings, Inc., a California corporation (“Licensee”).
POSTING AGREEMENTPosting Agreement • May 23rd, 2019 • Med-X, Inc. • Pharmaceutical preparations • New York
THIS POSTING AGREEMENT (the “Agreement”) is made as of May 17, 2019, between StartEngine Crowdfunding, Inc. (“StartEngine”), a Delaware corporation, and Med-X, Inc. a Nevada corporation (the “Company”), to act as the Company’s online intermediary technology platform (the “Platform”) in connection with the Company’s proposed offering promulgated under Regulation A (“Reg A+”) under the Securities Act of 1933, as amended (the “Securities Act”), (the “Offering”) of common or preferred stock (the “Securities”).
NMS Capital Advisors Engagement LetterEngagement Agreement • May 23rd, 2019 • Med-X, Inc. • Pharmaceutical preparations
NMS Capital Advisors, LLC (“NMS”) is pleased to provide this Engagement Agreement (this “Agreement”) to Med-X, Inc. (the “Company”). The purpose of this Agreement is to set forth the terms and conditions under which NMS will act as the Company’s exclusive financial advisor with respect to the Company’s proposed sale of up to 25,0000,000 shares of common stock, par value $0.01 per share (the “Common Stock”), in a Regulation A+, Tier 2 offering (the “Reg A Transaction”).
